MASSMUTUAL TRUST CO FSB/ADV - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 179 filers reported holding HAEMONETICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$1,026
-4.6%
120.0%0.00%
Q3 2023$1,075
+5.2%
120.0%0.00%
Q2 2023$1,022
+2.9%
120.0%0.00%
Q1 2023$993
+99200.0%
120.0%0.00%
Q4 2022$1
-100.0%
12
-78.6%
0.00%
Q3 2021$4,000560.00%
Q2 2015$000.00%
Q2 2014$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2014$9,777,000
-22.6%
3000.0%0.01%
-50.0%
Q4 2013$12,639,0003000.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders